Protas welcomes Annalisa Jenkins to Board of Directors
Dr Annalisa Jenkins brings over 25 years of life sciences experience to Protas.
The latest in smarter trials
As a not-for-profit, our mission is to enable whole-system change in clinical trials. This means sharing our approach and knowledge with our community. From news about Protas, our partnerships and trials, to advice and guidance, discover more about our world.
Protas continues global expansion of Cantata
Cantata platform is now being used in 12 countries, supporting 2 trials simultaneously.
Melanie Ivarsson joins Protas Board of Directors
Melanie Ivarsson OBE brings over 25 years of leadership in life sciences and clinical development to Protas.
Protas announces new agreement to streamline clinical trials with GSK
Protas will provide a variety of expertise to improve trial quality, speed, efficiency and participation, across therapeutic areas.
Cantata accelerates search for first dengue treatment
Protas' technology platform, Cantata, has been chosen to deliver the largest-ever dengue therapeutics trial.
New Chief Medical Officer and VP, Clinical Solutions to accelerate growth
Dr Marcelo Vaz and Michael Biron have been appointed, strengthening leadership as we expand our services and technology offering.